UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

Impact of Statins on Serial Coronary Calcification During Atheroma Progression and Regression

Journal of the American College of Cardiology, 2015-04, Vol.65 (13), p.1273-1282

2015

Volltextzugriff (PDF)

Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future options

The Lancet (British edition), 2019-08, Vol.394 (10199), p.697-708

2019

Volltextzugriff (PDF)

Mendelian Randomization Study of ACLY and Cardiovascular Disease

The New England journal of medicine, 2019-03, Vol.380 (11), p.1033-1042

2019

Volltextzugriff (PDF)

Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

The New England journal of medicine, 2011-12, Vol.365 (22), p.2078-2087

2011

Volltextzugriff (PDF)

Effect of Evolocumab on Coronary Plaque Composition

Journal of the American College of Cardiology, 2018-10, Vol.72 (17), p.2012-2021

2018

Volltextzugriff (PDF)

Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels

International journal of molecular sciences, 2022-08, Vol.23 (16), p.9417

2022

Volltextzugriff (PDF)

Meta-analysis of Comparative Efficacy of Increasing Dose of Atorvastatin Versus Rosuvastatin Versus Simvastatin on Lowering Levels of Atherogenic Lipids (from VOYAGER)

The American journal of cardiology, 2010, Vol.105 (1), p.69-76

2010

Volltextzugriff (PDF)

Induction of obesity impairs reverse cholesterol transport in ob/ob mice

PloS one, 2018-09, Vol.13 (9), p.e0202102-e0202102

2018

Volltextzugriff (PDF)

Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib

Journal of the American College of Cardiology, 2015-11, Vol.66 (20), p.2201-2210

2015

Volltextzugriff (PDF)

Protein carbamylation links inflammation, smoking, uremia and atherogenesis

Nature medicine, 2007-10, Vol.13 (10), p.1176-1184

2007

Volltextzugriff (PDF)

Effect of Torcetrapib on the Progression of Coronary Atherosclerosis

The New England journal of medicine, 2007-03, Vol.356 (13), p.1304-1316

2007

Volltextzugriff (PDF)

Colchicine exerts anti‐atherosclerotic and ‑plaque‐stabilizing effects targeting foam cell formation

The FASEB journal, 2023-04, Vol.37 (4), p.e22846-n/a

2023

Volltextzugriff (PDF)

Clinical Predictors of Plaque Progression Despite Very Low Levels of Low-Density Lipoprotein Cholesterol

Journal of the American College of Cardiology, 2010-06, Vol.55 (24), p.2736-2742

2010

Volltextzugriff (PDF)

Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)

BMJ open, 2023-04, Vol.13 (4), p.e069915-e069915

2023

Volltextzugriff (PDF)

World Heart Federation Cholesterol Roadmap 2022

Global heart, 2022-01, Vol.17 (1), p.75-75

2022

Volltextzugriff (PDF)

Peripheral Arterial Disease and Progression of Coronary Atherosclerosis

Journal of the American College of Cardiology, 2011-03, Vol.57 (10), p.1220-1225

2011

Volltextzugriff (PDF)

Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program

Cardiovascular diabetology, 2024-02, Vol.23 (1), p.63-63, Article 63

2024

Volltextzugriff (PDF)

Cholesterol Crystals Associate With Coronary Plaque Vulnerability In Vivo

Journal of the American College of Cardiology, 2015-02, Vol.65 (6), p.630-632

2015

Volltextzugriff (PDF)

Effect of ACAT Inhibition on the Progression of Coronary Atherosclerosis

The New England journal of medicine, 2006-03, Vol.354 (12), p.1253-1263

2006

Volltextzugriff (PDF)

Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits

Circulation (New York, N.Y.), 2005-03, Vol.111 (12), p.1543-1550

2005

Volltextzugriff (PDF)

Will Big Data Shine Light at the End of the Tunnel for HDL?

Journal of the American College of Cardiology, 2016-11, Vol.68 (19), p.2084-2085

2016

Volltextzugriff (PDF)

Randomised clinical trial using Coronary Artery Calcium Scoring in Australian Women with Novel Cardiovascular Risk Factors (CAC-WOMEN Trial): study protocol

BMJ open, 2022-12, Vol.12 (12), p.e062685-e062685

2022

Volltextzugriff (PDF)

High-density lipoproteins attenuate high glucose-impaired endothelial cell signaling and functions: potential implications for improved vascular repair in diabetes

Cardiovascular diabetology, 2017-09, Vol.16 (1), p.121-121, Article 121

2017

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

ThemaCholesterol

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)

Publikationsform

Artikel
(100)

Sprache

Englisch
(100)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of Statins on Serial Coronary Calcification During Atheroma Progression and Regression

Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future options

Mendelian Randomization Study of ACLY and Cardiovascular Disease

Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

Effect of Evolocumab on Coronary Plaque Composition

Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels

Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction

Meta-analysis of Comparative Efficacy of Increasing Dose of Atorvastatin Versus Rosuvastatin Versus Simvastatin on Lowering Levels of Atherogenic Lipids (from VOYAGER)

Induction of obesity impairs reverse cholesterol transport in ob/ob mice

Cholesterol Efflux Capacity and Pre-Beta-1 HDL Concentrations Are Increased in Dyslipidemic Patients Treated With Evacetrapib

Protein carbamylation links inflammation, smoking, uremia and atherogenesis

Effect of Torcetrapib on the Progression of Coronary Atherosclerosis

Colchicine exerts anti‐atherosclerotic and ‑plaque‐stabilizing effects targeting foam cell formation

Clinical Predictors of Plaque Progression Despite Very Low Levels of Low-Density Lipoprotein Cholesterol

Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)

World Heart Federation Cholesterol Roadmap 2022

Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial

Peripheral Arterial Disease and Progression of Coronary Atherosclerosis

Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program

Cholesterol Crystals Associate With Coronary Plaque Vulnerability In Vivo

Effect of ACAT Inhibition on the Progression of Coronary Atherosclerosis

Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits

Will Big Data Shine Light at the End of the Tunnel for HDL?

Randomised clinical trial using Coronary Artery Calcium Scoring in Australian Women with Novel Cardiovascular Risk Factors (CAC-WOMEN Trial): study protocol

High-density lipoproteins attenuate high glucose-impaired endothelial cell signaling and functions: potential implications for improved vascular repair in diabetes

Aktive Filter

Suchergebnisse filtern